India & United States — Presidency of Donald Trump

India: Merck plans to allow Indian manufacturers to produce generic alimatravir, potentially expanding access.

United States — Presidency of Donald Trump: The United States — Presidency of Donald Trump's policies, including dismantling USAID and cutting global health grants, are the primary cause of the disruptions to PEPFAR.

India: India>>> is among the 15 countries whose government agencies and private sector firms have secured access to Anthropic>>>'s Mythos AI model as part of Project Glasswing, enhancing its cybersecurity capabilities.

United States — Presidency of Donald Trump: The United States — Presidency of Donald Trump>>> struck deals with major tech companies to review their AI models for safety, indicating a broader policy shift that influenced the United States>>> government's engagement with Anthropic>>>.

India: India is one of the countries that negotiated a trade deal with the US.

United States — Presidency of Donald Trump: The administration's tariff policy is central to the event; it claims success and plans new tariffs, shaping US trade relations.

India: India is mentioned in a related article but is not directly involved in this event.

United States — Presidency of Donald Trump: The administration enacted the ban, reinforcing its hardline stance on Chinese technology.

India: The launch of Claude Mythos could impact India's technology ecosystem by providing advanced AI capabilities to software developers, startups, and IT services firms, potentially accelerating innovation.

United States — Presidency of Donald Trump: The United States — Presidency of Donald Trump previously had conflicts with Anthropic over restrictions on mass surveillance and autonomous lethal weapons, leading to the United States — The Pentagon ending contracts with the company.

United States — Presidency of Donald Trump: The United States — Presidency of Donald Trump, through Michael Kratsios, firmly opposed global Artificial intelligence governance, indicating a national stance against international regulatory frameworks.